Loading clinical trials...
Loading clinical trials...
Feasibility of Targeted Bronchial Washing Fluid for Molecular Testing With Next Generation Sequencing in Patients With Early-stage Non-small Cell Lung Cancer
This is a single center, clinical trial evaluating the relevance of intratumoral washing for detection of generic alteration with Next Generation Sequencing.
This is a prospective, single-arm, open-label study to assess evaluate the relevance of intratumoral washing by ultrathin bronchoscopy (outer diameter; 3mm) for detection of genetic alterations using Next Generation Sequencing in patients suspicious of early-stage lung cancer.
Age
20 - No limit years
Sex
ALL
Healthy Volunteers
No
Pusan National University Hospital
Busan, South Korea
Start Date
May 29, 2024
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2026
Last Updated
March 11, 2026
50
ESTIMATED participants
Ultarthin bronchoscopy with intratumoral washing
DIAGNOSTIC_TEST
Lead Sponsor
Pusan National University Hospital
NCT06498635
NCT06305754
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions